9-ING-41 in Patients with Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
University of Nebraska
Milton S. Hershey Medical Center
University of Southern California
UNC Lineberger Comprehensive Cancer Center
Heidelberg University
The Alvin and Lois Lapidus Cancer Institute